Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +44.45%
#2 Bitway Bitway +37.28%
#3 Pons Pons +37.06%
#4 Mubarak Mubarak +36.84%
#5 Ocean Protocol Ocean Protocol +34.14%
#6 Starpower Starpower +29.65%
#7 SkyAI SkyAI +21.90%
#8 Decred Decred +18.17%
#9 PondCoin PondCoin +18.16%
#10 TENDIES TENDIES +17.96%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
General Biologicals Corporation General Biologicals Corporation

General Biologicals Corporation

4117
Rank in Stocks #29238
General Biologicals Corporation (GBC) is a company dedicated to the research,... General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
Share Price
$0.31640033
Market Cap
$22.25M
Change (1 day)
-3.40%
Change (1 year)
-36.80%
Country
TW
Trade General Biologicals Corporation (4117)

Category

Healthcare
Operating Margin for General Biologicals Corporation (4117)
Operating Margin as of 2026 TTM: 0.00%
According to General Biologicals Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for General Biologicals Corporation from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
STERIS plc STERIS plc
STERIS plc
STE.US
18.91% -
IE
Shanghai United Imaging Healthcare Co., Ltd. Shanghai United Imaging Healthcare Co., Ltd.
Shanghai United Imaging Healthcare Co., Ltd.
688271.SS
0.00% -
CN
Ypsomed Holding AG Ypsomed Holding AG
Ypsomed Holding AG
YPSN.SW
0.00% -
CH
Medacta Group S.A. Medacta Group S.A.
Medacta Group S.A.
MOVE.SW
0.00% -
CH
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd.
300529.SZ
0.00% -
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.